USFDA grants orphan drug and pediatric exclusivities for Cresemba for aspergillosis and mucormycosis in children
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
The project aims at screening the general health condition of the students enrolled in classes 6th to 12th.
The CDCCs are strategically positioned in regions identified as high-impact areas
The 200 bedded hospital owned & operated by Alexis
Beneficiaries can create Ayushman Card from their mobile phone using Ayushman App which has been downloaded 52 lakh times since its launch on 13th September, 2023
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
The National Sickle Cell Anaemia Elimination Mission was launched on 1st July 2023 at Shahdol, Madhya Pradesh
Ami Organics recently announced contract with global MNC for manufacturing of electrolyte for battery cells
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections
Subscribe To Our Newsletter & Stay Updated